Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory or Relapsed Diffuse Large B Cell Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07249905
What this trial is testing

Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma

Who this might be right for
LymphomaWaldenström Macroglobulinemia (WM)DLBCL - Diffuse Large B Cell Lymphoma+5 more
ModeX Therapeutics, An OPKO Health Company 180
Testing effectiveness (Phase 2)Ended earlyNCT05896163
What this trial is testing

Learn About the Effects of Two Study Medicines (Maplirpacept [PF-07901801] And Glofitamab) When Given Together In People With Relapsed Or Refractory Diffuse Large B Cell Lymphoma.

Who this might be right for
Diffuse Large B-Cell Lymphoma
Pfizer 40
Testing effectiveness (Phase 2)Study completedNCT02564744
What this trial is testing

Study to Evaluate the Efficacy and Tolerability of Debio 1562 in Combination With Rituximab in Participants With Relapsed and/or Refractory DLBCL and Other Forms of NHL

Who this might be right for
Diffuse Large B-Cell LymphomaB-cell Non-Hodgkin's Lymphoma
Debiopharm International SA 100
Early research (Phase 1)Active Not RecruitingNCT04007029
What this trial is testing

Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
CD19 PositiveCD20 PositiveRecurrent Chronic Lymphocytic Leukemia+11 more
Jonsson Comprehensive Cancer Center 24
Early research (Phase 1)Ended earlyNCT03886649
What this trial is testing

Copanlisib in Combination With Venetoclax in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma.

Who this might be right for
Non-Hodgkin Lymphoma
Swiss Cancer Institute 7
Early research (Phase 1)Active Not RecruitingNCT05753501
What this trial is testing

Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies

Who this might be right for
Hematologic Cancer
AbbVie 135
Testing effectiveness (Phase 2)Ended earlyNCT00543582
What this trial is testing

MGCD0103 Administered in Combination With Azacitidine (Vidaza®) to Subjects With Relapsed or Refractory Hodgkin or Non-Hodgkin Lymphoma

Who this might be right for
Hodgkin LymphomaNon-Hodgkin Lymphoma (Follicular or Large Diffuse B-cell Lymphoma or Mantle Cell Lymphoma)
Mirati Therapeutics Inc. 23
Testing effectiveness (Phase 2)WithdrawnNCT03586024
What this trial is testing

Pembrolizumab in Relapsed or Refractory Extranodal NK/T- Cell Lymphoma, Nasal Type and EBV-associated Diffuse Large B Cell Lymphomas

Who this might be right for
Lymphoma
Abramson Cancer Center at Penn Medicine
Testing effectiveness (Phase 2)UnknownNCT01435720
What this trial is testing

Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL)

Who this might be right for
Multiple MyelomaMultiple Myeloma in RelapseMantle Cell Lymphoma in Relapse+3 more
Senesco Technologies, Inc. 15
Not applicableStudy completedNCT00856388
What this trial is testing

Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+97 more
Roswell Park Cancer Institute 62
Testing effectiveness (Phase 2)Study completedNCT00062296
What this trial is testing

Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
Fox Chase Cancer Center 5
Testing effectiveness (Phase 2)Study completedNCT02226965
What this trial is testing

PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)

Who this might be right for
Lymphoma, Diffuse Large B-Cell
Sierra Oncology LLC - a GSK company 45
Testing effectiveness (Phase 2)Ended earlyNCT02361346
What this trial is testing

Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL

Who this might be right for
Non-Hodgkin's B-cell LymphomaLeukemia, Lymphocytic, Chronic, B-CellSmall Lymphocytic Leukemia+3 more
Molecular Templates, Inc. 38
Testing effectiveness (Phase 2)WithdrawnNCT04456023
What this trial is testing

Study of Tisagenlecleucel in Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-cell Non-Hodgkin Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-Cell Lymphoma (DLBCL)
Novartis Pharmaceuticals
Not applicableLooking for participantsNCT06299553
What this trial is testing

Study to Evaluate the Effectiveness of Tafasitamab in Combination With Lenalidomide Followed by Tafasitamab Monotherapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma Non-transplant Eligible Patients in Italy (PRO-MIND)

Who this might be right for
DLBCL - Diffuse Large B Cell Lymphoma
Incyte Biosciences Italy S.r.l 200
Not applicableStudy completedNCT04981795
What this trial is testing

RealMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL

Who this might be right for
Diffuse Large B-cell Lymphoma
Incyte Corporation 102
Testing effectiveness (Phase 2)Study completedNCT01177371
What this trial is testing

High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+70 more
Case Comprehensive Cancer Center 13
Not applicableStudy completedNCT00098566
What this trial is testing

Long-Term Effects of Iodine I Tositumomab and Autologous Bone Marrow or Stem Cell Transplantation in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaQuality of Life
Fred Hutchinson Cancer Center 36
Testing effectiveness (Phase 2)Ended earlyNCT03422523
What this trial is testing

Atezolizumab, Rituximab, Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory DLBCL Not Suitable for High-dose Therapy

Who this might be right for
Diffuse Large B Cell LymphomaRelapsed Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma
University Hospital Southampton NHS Foundation Trust 53
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07713459
What this trial is testing

A Phase II Study to Evaluate the Efficacy of UF-KURE19 Cells in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

Who this might be right for
Lymphoma NonhodgkinMarginal Zone B Cell LymphomaDiffuse Large B Cell Lymphoma (DLBCL)+2 more
Kure Cells, INC 105
Next Page